Economic Dimensions of Personalized and Precision Medicine
Ernst R. Berndt, Dana P. Goldman, and John W. Rowe, editor
Conference held September 13-14, 2017
Published in April 2019 by University of Chicago Press
© 2019 by the National Bureau of Economic Research
NBER Program(s):HE, HC
More information on purchasing this book
349 pages
ISBN: 978-0-226-61106-8
Table of Contents
|
Front matter, acknowledgments:
(bibliographic info)
(download)
|
|
|
Introduction:
Ernst R. Berndt, Dana P. Goldman, John W. Rowe
(p. 1 - 7)
(bibliographic info)
(download)
|
|
|
1.
The Economic Value and Pricing of Personalized Medicine:
Tomas J. Philipson
(p. 9 - 19)
(bibliographic info)
(download)
|
|
|
2.
Therapeutic Translation of Genomic Science: Opportunities and Limitations of GWAS:
Manuel Hermosilla, Jorge Lemus
(p. 21 - 52)
(bibliographic info)
(download)
(Working Paper version)
|
|
|
3.
The Value of Pharmacogenomic Information:
John A. Graves, Zilu Zhou, Shawn Garbett, Josh F. Peterson
(p. 53 - 86)
(bibliographic info)
(download)
(Working Paper version)
|
|
|
4.
The Information Pharms Race and Competitive Dynamics of Precision Medicine: Insights from Game Theory:
Ernst R. Berndt, Mark R. Trusheim
(p. 87 - 114)
(bibliographic info)
(download)
(Working Paper version)
|
|
|
5.
Characterizing the Drug Development Pipeline for Precision Medicines:
Amitabh Chandra, Craig Garthwaite, Ariel Dora Stern
(p. 115 - 157)
(bibliographic info)
(download)
(Working Paper version)
|
|
|
6.
Cost Sharing in Insurance Coverage for Precision Medicine:
Mark V. Pauly
(p. 159 - 184)
(bibliographic info)
(download)
(Working Paper version)
|
|
|
7.
Measuring the Potential Health Impact of Personalized Medicine: Evidence from Multiple Sclerosis Treatments:
Kristopher J. Hult
(p. 185 - 216)
(bibliographic info)
(download)
(Working Paper version)
|
|
|
8.
Physicians’ Financial Incentives to Personalize Medicine:
David H. Howard, Jason Hockenberry, Guy David
(p. 217 - 235)
(bibliographic info)
(download)
(Working Paper version)
|
|
|
9.
Economic Dimensions of Personalized and Precision Medicine in Asia: Evidence from Breast Cancer Treatment in Taiwan:
Jui-fen Rachel Lu, Karen Eggleston, Joseph Tung-Chieh Chang
(p. 237 - 272)
(bibliographic info)
(download)
|
|
|
10.
The Value of Cytochrome P450 2C19 Pharmacogenomic Information for Patients Receiving Clopidogrel Therapy Following a Major Cardiovascular Event: Evidence from Geisinger:
Rebecca A. Pulk, Jove Graham, Frank R. Lichtenberg, Daniel Maeng, Marc S. Williams, Eric Wright
(p. 273 - 304)
(bibliographic info)
(download)
|
|
|
11.
Orphan Drug Designations as Valuable Intangible Assets for IPO Investors in Pharma-Biotech Companies:
Philippe Gorry, Diego Useche
(p. 305 - 334)
(bibliographic info)
(download)
|
|
|
List of contributors, indexes:
(p. 335 - 349)
(bibliographic info)
(download)
|
|
|
